Results 71 to 80 of about 10,825 (231)

Serotonin Noradrenaline Reuptake Inhibitors (SNRIs) [PDF]

open access: yes, 2012
Antidepressants that block the reuptake of serotonin (5-HT) and noradrenaline (NA) are called 5-HT and NA reuptake inhibitors (SNRIs). SNRIs are agents that show “dual action” on 5-HT and NA. These drugs bind the 5-HT transporters (SERT) and NA transporters (NAT) similar to tricyclic antidepressants (TCAs). However, SNRIs differ from TCAs in that SNRIs
Ipek Komsuoglu, Oguz Mutlu, Guner Ulak
openaire   +1 more source

The Impact of Common Medications on Male Fertility: An Updated Systematic Review

open access: yesAndrology, EarlyView.
ABSTRACT Background Compared with those of cytotoxic treatments, the potential effects of common medications on the fertility of men trying to conceive currently or planning to conceive in the future are less well described. The use of common medications may modify the gonadotropic axis, spermatogenesis, and epididymal maturation or alter male ...
Lina Jebli   +7 more
wiley   +1 more source

sj-docx-1-jop-10.1177_02698811231179910 – Supplemental material for Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use

open access: yes, 2023
Supplemental material, sj-docx-1-jop-10.1177_02698811231179910 for Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use by Natalie Gukasyan, Roland R. Griffiths, David B. Yaden, Denis G. Antoine and Sandeep M. Nayak in
Natalie Gukasyan (9965504)   +4 more
core   +1 more source

Molecular adaptation to chronic antidepressant treatment: evidence for a more rapid response to the novel α₂-adrenoceptor antagonist/5-HT-noradrenaline reuptake inhibitor (SNRI), S35966, compared to the SNRI, venlafaxine.

open access: yes, 2012
Evidence of early changes in neural plasticity may aid the prediction of rapid-onset antidepressant drugs. Here we compared the dual α₂-adrenoceptor antagonist/5-HT-noradrenaline reuptake inhibitor (SNRI), S35966, to the SNRI, venlafaxine, with regards ...
Serres, F   +3 more
core   +1 more source

sj-docx-2-jop-10.1177_02698811231179910 – Supplemental material for Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use

open access: yes, 2023
Supplemental material, sj-docx-2-jop-10.1177_02698811231179910 for Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use by Natalie Gukasyan, Roland R. Griffiths, David B. Yaden, Denis G. Antoine and Sandeep M. Nayak in
Natalie Gukasyan (9965504)   +4 more
core   +1 more source

喉頭異常感症に対するボノプラザンフマル酸塩とSNRIの効果 : GETS-J(日本語版GETS)を用いた評価 [PDF]

open access: yes, 2021
新潟大学Niigata University博士(医学)Purpose To determine patients with abnormal sensation in the throat (AST) who would respond to potassium-competitive acid blocker (P-CAB) or serotonin noradrenaline reuptake inhibitor (SNRI) treatment.
Takahashi, Nao, 高橋, 奈央
core   +1 more source

Menopausal status at the age of 46: Its association with depressive and anxiety symptoms and morbidity in women—A northern Finland birth cohort 1966 study

open access: yesActa Obstetricia et Gynecologica Scandinavica, EarlyView.
Women who are perimenopausal or menopausal at age 46 have a higher risk of anxiety and depressive symptoms than premenopausal women. Early‐onset menopause highlights the need for mental health support during and after the menopausal transition. Abstract Introduction The incidence of several morbidities increases during the menopausal transition ...
Tiia Saarinen   +4 more
wiley   +1 more source

Use of selective serotonin reuptake inhibitors and risk of myeloid malignancy: A nationwide Danish case–control study

open access: yesBritish Journal of Haematology, EarlyView.
Summary Preclinical and clinical studies suggest that selective serotonin reuptake inhibitors (SSRIs) can stimulate haematopoiesis by promoting proliferation and mobilization of haematopoietic stem and progenitor cells, but whether SSRI use influences myeloid malignancy risk remains unclear.
Katrine Mose   +5 more
wiley   +1 more source

Novel approaches for drug development against chronic primary pain: A systematic review

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus   +5 more
wiley   +1 more source

A systematic review and meta-analysis of randomized controlled head-to-head trials of recommended drugs for neuropathic pain

open access: yesPAIN Reports
. Neuropathic pain is a challenging chronic pain condition. Limited knowledge exists regarding the relative effectiveness of pharmacological treatments, and differences in trial design and impact of the placebo response preclude indirect comparisons of ...
Ayda Asadizadeh Sadegh   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy